Suggestions
Idioma
Guide for authors
Searcher
Journal Information
Vol. 22. Issue 7.
(August - September 2026)
Cite
Cite
Share
Download PDF
More article options
Vol. 22. Issue 7.
(August - September 2026)
Carta al Editor

Tuberculosis latente en pacientes reumatológicos bajo terapia biológica: consideraciones metodológicas y perspectiva desde la atención primaria

Latent tuberculosis in rheumatological patients on biologic therapy: methodological considerations and primary care perspective
Visits
745
Juan Sebastián Therán Leóna,
Corresponding author
jtheran554@unab.edu.co

Autor para correspondencia.
, Liliana Cristina Díaz Cruzb, Gustavo Andrés Díaz Cruzc
a Médico Familiar, Universidad de Santander (UDES). Sub-investigador, SERVIMED Clinical Research Center, Bucaramanga, Santander, Colombia
b Médico General. Universidad Industrial de Santander (UIS), Bucaramanga, Santander, Colombia
c Médico General. Universidad Autónoma de Bucaramanga (UNAB), Bucaramanga, Santander, Colombia
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics

Article

These are the options to access the full texts of the publication Reumatología Clínica (English Edition)
Member
If you are member of Sociedad Española de Reumatología (SER) or the Colegio Mexicano de Reumatología (CMR):
Please go to the member area of SER or CMR and log in.
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to
Reumatología Clínica (English Edition)
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Bibliografía
[1]
L.F. Valdés Corona, A. González Andrade, A. Luna Salazar, et al.
Prevalencia de tuberculosis latente en pacientes con enfermedades reumatológicas expuestos a medicamentos biológicos y moléculas pequeñas: un estudio basado en el registro nacional BIOBADAMEX.
[2]
World Health Organization.
WHO Consolidated Guidelines on Tuberculosis Module 1: Prevention. Tuberculosis Preventive Treatment.
WHO, (2020),
[3]
U. Sester, H. Wilkens, K. van Bentum, et al.
Impaired detection of Mycobacterium tuberculosis immunity in patients using immunosuppressive drug regimens.
Eur Respir J., 34 (2009), pp. 702-710
[4]
M. Farhat, C. Greenaway, M. Pai, D. Menzies.
False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?.
Int J Tuberc Lung Dis., 10 (2006), pp. 1192-1204
[5]
S.P. Parihar, R. Guler, R. Khutlang, et al.
Statin therapy reduces the Mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation.
J Infect Dis., 209 (2014), pp. 754-763
[6]
Organización Panamericana de la Salud.
Plan de acción para la prevención y el control de la tuberculosis 2023-2025.
OPS, (2023),
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools